Antibiotic Class |
Interacting Drug |
Comment |
Tetracyclines e.g.
- Doxycycline
- Lymecycline
- Minocycline
|
Antacids, Zinc, Calcium, Magnesium, Aluminium, Sucralfate and Bismuth Preparations |
Risk of reduced bioavailability and efficacy of tetracyclines. Separate the doses by 2 to 3 hours or more to avoid interaction. |
Iron |
Iron to be given 3 hours before or 2-3 hours after the tetracyclines. The absorption of both the tetracyclines and iron compounds is greatly reduced by concurrent use. |
Warfarin |
Risk of bleeding - monitor INR closely. |
Methotrexate |
Tetracyclines can increase risk of methotrexate toxicity. |
Systemic retinoids. e.g. Oral isotretinoin |
Concomitant use of retinoids and tetracyclines is contraindicated due to risk of causing benign intracranial hypertension. |
Antiepileptics |
Doxycycline levels may be reduced. Monitor for efficacy and consider increase in doxycycline dose. |
Rifampicin |
Doxycycline levels may be reduced. Monitor for efficacy and consider increase in doxycycline dose. |
Ciclosporin |
Doxycycline is predicted to increase ciclosporin concentrations. Action: monitor (and dose adjust the ciclosporin as needed). |
Lithium |
Tetracyclines might increase the risk of lithium toxicity when given with lithium. Action: monitor for lithium toxicity and adjust the dose as needed. |
Strontium |
Suspend strontium ranelate treatment if tetracycline needed. |
Cyproterone |
Monitor for pigmentation with minocycline. |
Combined oral contraceptive |
Monitor for pigmentation with minocycline. |